CSIMarket
 


Iterum Therapeutics Plc  (ITRM)
Other Ticker:  
 
 

ITRM's Capital Expenditures Growth by Quarter and Year

Iterum Therapeutics Plc's Capital Expenditures results by quarter and year




ITRM Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.01 0.00
III Quarter September 0.00 0.00 0.05 0.01
II Quarter June 0.02 0.01 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.02 0.01 0.06 0.01



ITRM Capital Expenditures third quarter 2023 Y/Y Growth Comment
Iterum Therapeutics Plc in the third quarter 2023 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the third quarter 2023, Iterum Therapeutics Plc achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Iterum Therapeutics Plc' s Capital Expenditures no change of % ranks overall at the positon no. in the third quarter 2023.




ITRM Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - 400 % -
II Quarter June 100 % - - -
I Quarter March - - - -
FY   - -83.33 % 500 % -50 %

Financial Statements
Iterum Therapeutics Plc's third quarter 2023 Capital Expenditures $ 0.00 millions ITRM's Income Statement
Iterum Therapeutics Plc's third quarter 2022 Capital Expenditures $ 0.00 millions Quarterly ITRM's Income Statement
New: More ITRM's historic Capital Expenditures Growth >>


ITRM Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - -80 % -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - -83.33 % 500 % -50 %




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Iterum Therapeutics Plc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ITRM's III. Quarter Q/Q Capital Expenditures Comment
III. Quarter 2023 Capital Expenditures of 0.00 millions by Iterum Therapeutics Plc look even more unfavourable considering the 0.02 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Iterum Therapeutics Plc achieved highest sequential Capital Expenditures growth. While Iterum Therapeutics Plc's Capital Expenditures growth quarter on quarter, overall rank is .


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ITRM's III. Quarter Q/Q Capital Expenditures Comment
Current accomplishment of 0.00 millions by Iterum Therapeutics Plc look even less good if you take a look at 0.02 millions Capital Expenditures in the second quarter.

Within Major Pharmaceutical Preparations industry Iterum Therapeutics Plc achieved highest sequential Capital Expenditures growth. While Iterum Therapeutics Plc's Capital Expenditures growth quarter on quarter, overall rank is .


Iterum Therapeutics Plc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Sep 30 2023 period, Iterum Therapeutics Plc's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Iterum Therapeutics Plc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Sep 30 2023 period, Iterum Therapeutics Plc's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Iterum Therapeutics Plc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
ITRM's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for ITRM's Competitors
Capital Expenditures Growth for Iterum Therapeutics Plc's Suppliers
Capital Expenditures Growth for ITRM's Customers

You may also want to know
ITRM's Annual Growth Rates ITRM's Profitability Ratios ITRM's Asset Turnover Ratio ITRM's Dividend Growth
ITRM's Roe ITRM's Valuation Ratios ITRM's Financial Strength Ratios ITRM's Dividend Payout Ratio
ITRM's Roa ITRM's Inventory Turnover Ratio ITRM's Growth Rates ITRM's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Encompass Health Corporation-0.54%$ -0.542 millions
Myriad Genetics Inc -1.13%$ -1.130 millions
Opgen inc -1.22%$ -1.220 millions
Avantor Inc -3.33%$ -3.333 millions
United Therapeutics Corporation-4.51%$ -4.506 millions
Enanta Pharmaceuticals Inc-4.80%$ -4.802 millions
Davita Inc -5.46%$ -5.463 millions
Science 37 Holdings Inc -5.63%$ -5.630 millions
Cutera Inc -5.71%$ -5.708 millions
Zoetis Inc -5.84%$ -5.844 millions
U S Physical Therapy Inc-6.25%$ -6.248 millions
Generation Bio Co -6.30%$ -6.298 millions
Ngm Biopharmaceuticals Inc -6.45%$ -6.452 millions
Becton Dickinson And Company-6.67%$ -6.667 millions
3m Company-6.90%$ -6.897 millions
Apyx Medical Corporation-7.45%$ -7.447 millions
Edwards Lifesciences Corporation-7.68%$ -7.679 millions
Viatris Inc -7.70%$ -7.700 millions
Luna Innovations Inc-8.23%$ -8.232 millions
Nevro Corp -8.38%$ -8.377 millions
Shockwave Medical Inc -8.65%$ -8.649 millions
Sonendo Inc -8.86%$ -8.861 millions
Charles River Laboratories International inc -8.90%$ -8.904 millions
Nautilus Biotechnology Inc -9.24%$ -9.242 millions
Harvard Bioscience Inc-9.28%$ -9.276 millions
Fulgent Genetics Inc -9.42%$ -9.420 millions
Idexx Laboratories Inc-9.53%$ -9.529 millions
Sage Therapeutics Inc -9.89%$ -9.890 millions
Caredx Inc -10.40%$ -10.400 millions
Quest Diagnostics Inc-11.02%$ -11.017 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com